7,580.07

-140.32

-1.82%

51,770.31

-572.25

-1.09%

25,437.00

-747.73

-2.86%

2,811.84

-47.37

-1.66%

4.9290

-0.0600

-1.20%

19.42

+2.22

+12.91%

3,898.90

-132.50

-3.29%

77,891.24

+429.32

+0.55%

Crude Oil Dec 26

104.12

+2.12

+2.08%

US Private Equity

10,850.63

-82.20

-0.75%

OTC Markets OTCQB - Delayed Quote USD

Protagenic Therapeutics, Inc. (PTIX)

0.6380 -0.0080 (-1.24%)

At close: October 30 at 4:00:00 PM EDT

 All 
 News 
 Earnings Calls 
 Press Releases 
 SEC Filings 

Protagenic Therapeutics Appoints Industry Veteran Bill Nichols Jr. as President to Accelerate Advancement of First-in-Class TCAP Pathway Therapy PT00114

ACCESS Newswire 6mo ago

PTIX
-1.24%
BMY
Protagenic Therapeutics Engages Floyd Regulatory Strategic Consulting as Regulatory Affairs Advisor and Danforth Health as Strategic Operations Partner

ACCESS Newswire 5mo ago

PTIX
-1.24%
Protagenic Therapeutics Receives FDA Pre-IND Feedback Supporting New IND for PT00114 in Generalized Anxiety Disorder

ACCESS Newswire 2mo ago

PTIX
-1.24%
Protagenic Therapeutics' Lead Candidate PT00114 Attenuated Chronic Stress Responses in a Well-Established Rodent Model

ACCESS Newswire 4mo ago

PTIX
-1.24%
Protagenic Therapeutics Completes Phytanix Separation, Strengthens Balance Sheet and Repositions the Company Around PT00114

ACCESS Newswire 7mo ago

PTIX
-1.24%
Protagenic Therapeutics Upgrades from OTC Pink to OTCQB Venture Market

ACCESS Newswire 7mo ago

PTIX
-1.24%
Results from Phase 1 Multiple-Dose Study of PT00114

ACCESS Newswire 10mo ago

PTIX
-1.24%
Protagenic Therapeutics Announces Receipt of Nasdaq Non-Compliance Notice

ACCESS Newswire 10mo ago

PTIX
-1.24%

Performance Overview

Return	PTIX	S&P 500 (^GSPC)
YTD	-50.92%	+10.73%
1-Year	-74.17%	+11.11%
3-Year	-94.31%	+81.91%

Mobilize your Website

View Site in Mobile | Classic

Share by: